RecruitingPhase 3NCT07037433
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Sponsor: Amgen
Wilmington, DE · +139 more sites
5 recruiting obesity studies with a site in Wilmington, DE.
Sponsor: Amgen
Wilmington, DE · +139 more sites
Sponsor: Russell McCulloh, MD
Wilmington, DE · +7 more sites
Sponsor: Eli Lilly and Company
Wilmington, DE · +13 more sites
Sponsor: Harmony Biosciences Management, Inc.
Wilmington, DE · +22 more sites
Sponsor: Nemours Children's Clinic
Wilmington, DE
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.